Civic Intelligence

Global Hiv Vaccine Enterprise

990 • Fiscal year 2013 • EIN 20-3347314

Jan 01, 2013 to Dec 31, 2013

Organization Profilewww.vaccineenterprise.org
Brooklyn, NY
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

44th percentile

0.08x

Higher debt load relative to assets than 44% of similar nonprofits.

2013 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2013

Liabilities / Revenue

46th percentile

0.09x

Higher debt load relative to revenue than 46% of similar nonprofits.

2013 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2013

Net Margin

12th percentile

-24%

Higher net margin than 12% of similar nonprofits.

2013 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2013

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2013

Asset Growth

8th percentile

-17%

Faster asset growth than 8% of similar nonprofits.

2013 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2012 to 2013

Revenue Growth

23rd percentile

-8.6%

Faster revenue growth than 23% of similar nonprofits.

2013 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2012 to 2013

Balance Sheet
Liabilities / Assets44th percentile

Assets

Down

$3,755,433

Down $757,378 (-17%) from 2012

Net Assets

Down

$3,459,628

Down $799,989 (-19%) from 2012

Liabilities

Up

$295,805

Up $42,611 (+17%) from 2012

Revenue And Expenses
Liabilities / Revenue46th percentileNet Margin12th percentile

Revenue

Down

$3,364,456

Down $318,526 (-8.6%) from 2012

Expenses

Up

$4,164,445

Up $821,695 (+25%) from 2012

Net Income

Down

-$799,989

Down $1,140,221 (-335%) from 2012

Historical Trend

Balance Sheet Trend

Asset Growth8th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$8.0M$6.0M$4.0M$2.0M$0Assets 2010: $6,522,922Liabilities 2010: $180,467Net Assets 2010: $6,342,4552010Assets 2011: $4,063,293Liabilities 2011: $143,908Net Assets 2011: $3,919,3852011Assets 2012: $4,512,811Liabilities 2012: $253,194Net Assets 2012: $4,259,6172012Assets 2013: $3,755,433Liabilities 2013: $295,805Net Assets 2013: $3,459,6282013Assets 2014: $5,918,954Liabilities 2014: $1,311,734Net Assets 2014: $4,607,2202014Assets 2015: $4,677,175Liabilities 2015: $815,408Net Assets 2015: $3,861,7672015Assets 2016: $4,450,065Liabilities 2016: $624,036Net Assets 2016: $3,826,0292016Assets 2017: $2,976,032Liabilities 2017: $1,687,764Net Assets 2017: $1,288,2682017

Highlighted filing

2013

Assets$3,755,433
Liabilities$295,805
Net Assets$3,459,628
Open 2013 Filing

Operations Trend

Revenue Growth23rd percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$10M$5.0M$0-$5.0MRevenue 2010: $2,609,734Expenses 2010: $5,296,628Net Income 2010: -$2,686,8942010Revenue 2011: $2,246,515Expenses 2011: $4,669,809Net Income 2011: -$2,423,2942011Revenue 2012: $3,682,982Expenses 2012: $3,342,750Net Income 2012: $340,2322012Revenue 2013: $3,364,456Expenses 2013: $4,164,445Net Income 2013: -$799,9892013Revenue 2014: $5,878,271Expenses 2014: $4,730,679Net Income 2014: $1,147,5922014Revenue 2015: $2,095,581Expenses 2015: $2,841,034Net Income 2015: -$745,4532015Revenue 2016: $4,926,868Expenses 2016: $4,870,631Net Income 2016: $56,2372016Revenue 2017: $1,160,530Expenses 2017: $3,698,291Net Income 2017: -$2,537,7612017

Highlighted filing

2013

Revenue$3,364,456
Expenses$4,164,445
Net Income-$799,989
Open 2013 Filing
Filing Detail Status

This 2013 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

View Latest Detailed Filing (2017)
Jump To
Filing Snapshot
Filing Period
Jan 1, 2013 to Dec 31, 2013
Mission and Program Overview

Mission

The global hiv vaccine enterprise (the enterprise) is an alliance of independent organizations dedicated to accelerating the development of safe and effective hiv vaccines for use globally. It moves vaccine research and development forward among organizations through coordination, collaboration, knowledge-sharing and efforts to attract interest, resources and funders to the field. Since 2014, the enterprise has hosted the successful, new, biennial hiv research for prevention (hivr4p) conference. Hivr4p, the worlds only scientific meeting dedicated exclusively to biomedical hiv prevention research, brings together policy experts, funders, stakeholders and others to share and discuss the latest scientific developments from all hiv prevention disciplines and approaches, including their distinctive features, commonalities and combination.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2013 • Form 990Summary only. Only limited summary data is available for this year.

Open filing
Assets
$3,755,433
Liabilities
$295,805
Net assets
$3,459,628
Revenue
$3,364,456
Expenses
$4,164,445
Net income
-$799,989
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2017Facts available. Structured filing facts are available, but richer extracted sections are limited.$2.98$1.69$1.29$1.16$3.70$2.54
2016Summary only. Only limited summary data is available for this year.$4.45$0.62$3.83$4.93$4.87$0.06
2015Summary only. Only limited summary data is available for this year.$4.68$0.82$3.86$2.10$2.84$0.75
2014Summary only. Only limited summary data is available for this year.$5.92$1.31$4.61$5.88$4.73$1.15
2013Summary only. Only limited summary data is available for this year.$3.76$0.30$3.46$3.36$4.16$0.80
2012Summary only. Only limited summary data is available for this year.$4.51$0.25$4.26$3.68$3.34$0.34
2011Summary only. Only limited summary data is available for this year.$4.06$0.14$3.92$2.25$4.67$2.42
2010Summary only. Only limited summary data is available for this year.$6.52$0.18$6.34$2.61$5.30$2.69